TARDIVE DYSKINESIA
Clinical trials for TARDIVE DYSKINESIA explained in plain language.
Never miss a new study
Get alerted when new TARDIVE DYSKINESIA trials appear
Sign up with your email to follow new studies for TARDIVE DYSKINESIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study shows valbenazine may ease involuntary movements in mental health patients
Symptom relief CompletedThis study looked at how well valbenazine works for tardive dyskinesia, a condition causing uncontrollable movements often linked to psychiatric medications. Fifty-nine adults with schizophrenia, bipolar disorder, or major depression took valbenazine for up to 24 weeks. Researche…
Matched conditions: TARDIVE DYSKINESIA
Phase: PHASE4 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
New drug shows promise for calming uncontrollable body movements
Symptom relief CompletedThis study tested a daily pill called MT-5199 to see if it could reduce symptoms of tardive dyskinesia, a condition that causes uncontrollable movements of the face, mouth, arms, legs, and trunk. The study involved 256 adults with moderate to severe tardive dyskinesia who also ha…
Matched conditions: TARDIVE DYSKINESIA
Phase: PHASE2, PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
Hope for tardive dyskinesia: new trial tests tetrabenazine
Symptom relief CompletedThis study tested a drug called tetrabenazine (Xenazine) in 54 adults with tardive dyskinesia, a condition causing uncontrollable movements after long-term antipsychotic use. The goal was to see if the drug could reduce these movements better than a placebo over 10 weeks. The tri…
Matched conditions: TARDIVE DYSKINESIA
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated May 11, 2026 20:40 UTC